Absci Corp Reports Q2 2026 Results; Releases Pipeline Presentation

What Happened

• Absci Corporation announced its financial results for the quarter ended June 30, 2026 in a press release dated August 11, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K.
• On the same date the company released a corporate presentation that includes certain internal pipeline program updates; that presentation is available on Absci’s “News & Events” webpage and is filed as Exhibit 99.2 to the Form 8-K.

Key Details

• Announcement date: August 11, 2026; reporting period: quarter ended June 30, 2026.
• Press release with the quarterly results: Exhibit 99.1 to the Form 8-K.
• Corporate presentation with internal pipeline updates: Exhibit 99.2; incorporated by reference and posted on the company website.
• Form 8-K signed by Chief Legal Officer Shelby Walker on behalf of Absci Corporation.

Why It Matters

• The filing gives investors the company’s latest quarterly results and an update on internal drug/protein discovery programs (pipeline), both material for assessing near-term performance and progress on R&D milestones.
• Investors should review the Exhibit 99.1 press release for the specific financial figures (revenue, earnings/loss, cash position, guidance if provided) and Exhibit 99.2 for program-level updates and timelines.
• No executive changes, mergers, or other corporate actions were reported in this filing; the items focus on operating results and investor communications.